Next, the enhanced tumor-suppressive efficacy of C/M@Alb NCs was validated by H&E, Ki67, and TUNEL (terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick end labeling) staining following previous protocols with some modifications [46]. Here, ALB is linked to neoplasm.